Experts join new group as therapy moves into phase 2b
R1 Therapeutics forms advisory board to support advancement of AP306
Experts join new group as therapy moves into phase 2b
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.